1.Identification of a novel STK11 gene mutation in a family affected with hereditary Peutz-Jeghers syndrome.
Cuiyang XU ; Yue MA ; Fei CAO ; He ZHAO ; Yongjie WANG ; Zewen XIAO ; Jiebing TANG ; Feihu YAN ; Peng SUN ; Na ZHANG ; Ji TAO
Chinese Journal of Medical Genetics 2018;35(1):89-91
OBJECTIVE To explore the genetic basis for a family affected with Peutz-Jeghers syndrome (PJS). METHODS Genomic DNA was extracted from peripheral blood and oral swab samples from the patient and her relatives. Next-generation sequencing (NGS) was used to analyze 106 target genes by capturing the exons and adjacent intronic regions. Suspected pathogenic mutation was verified by NGS. RESULTS A missense STK11 mutation was detected in the proband, which was not reported previously. The mutation has caused substitution of Leucine by Proline. NGS has detected the same mutation in the mother but not among other relatives. CONCLUSION This hereditary case of PJS may be attributed to the missense mutation of the STK11 gene.
2.Effects of radiation therapy on tumor microenvironment: an updated review.
Zewen ZHANG ; Yuanhao PENG ; Xin PENG ; Desheng XIAO ; Ying SHI ; Yongguang TAO
Chinese Medical Journal 2023;136(23):2802-2811
Cancer is a major threat to human health and causes death worldwide. Research on the role of radiotherapy (RT) in the treatment of cancer is progressing; however, RT not only causes fatal DNA damage to tumor cells, but also affects the interactions between tumor cells and different components of the tumor microenvironment (TME), including immune cells, fibroblasts, macrophages, extracellular matrix, and some soluble products. Some cancer cells can survive radiation and have shown strong resistance to radiation through interaction with the TME. Currently, the complex relationships between the tumor cells and cellular components that play major roles in various TMEs are poorly understood. This review explores the relationship between RT and cell-cell communication in the TME from the perspective of immunity and hypoxia and aims to identify new RT biomarkers and treatment methods in lung cancer to improve the current status of unstable RT effect and provide a theoretical basis for further lung cancer RT sensitization research in the future.
Humans
;
Neoplasms/pathology*
;
Lung Neoplasms/complications*
;
Fibroblasts/pathology*
;
Biomarkers
;
Macrophages/pathology*
;
Hypoxia
;
Tumor Microenvironment